Direct and indirect economic burden of lung cancer in Denmark a nationwide study

Figures & data

Table 1. Health costs and income before and after diagnosis of lung cancer for cases and controls. Yearly average costs per person. N =  summarized number of individuals × years observed. P-value from bootstrapped t -test. The values given are in euros (€)

			Case	Control	P-value
Before	N		292,721	1,164,791
	Outpatient treatment	€	319	234	< 0.01
	Inpatient treatment	€	1,441	972	< 0.01
	Medication	€	604	464	< 0.01
	Public health insurance	€	294	281	< 0.01
	Income from employment	€	9,893	12,895	< 0.01
	Public transfer income total	€	12,117	10,886
	Pension	€	6,807	6,695	< 0.01
	Other public transfers	€	4,993	3,976	< 0.01
	Sickpay (public funded)	€	318	214	< 0.01
	Direct health costs	€	2,658	1,952
	Indirect costs, foregone earnings	€	3,001
	Sum of direct and indirect costs	€	5,659	1,952
	Net costs	€	3,707
	Social transfer payments	€	12,117	10,886
	Net costs including transfers	€	4,939
After	N		114,709	1,214,124
	Outpatient treatment	€	2,794	430	< 0.01
	Inpatient treatment	€	11,183	1,816	< 0.01
	Medication	€	1,049	622	< 0.01
	Public health insurance	€	439	362	< 0.01
	Income from employment	€	5,566	7,992	< 0.01
	Public transfer income total	€	11,426	12,816
	Pension	€	6,879	10,161	< 0.01
	Other public transfers	€	3,476	2,498	< 0.01
	Sickpay (public funded)	€	1,070	156	< 0.01
	Direct health costs	€	15,464	3,229
	Indirect costs, foregone earnings	€	2,425
	Sum of direct and indirect costs	€	17,889	3,229
	Net costs	€	14,660
	Social transfer payments	€	11,426	12,816
	Net costs including transfers	€	13,270

Figure 1. Total health expenses in euros (€) for lung cancer patients (cases – green) compared to controls (blue) before and after being diagnosed with lung cancer

Figure 2. Health costs of lung cancer patients and controls in euros (€) distributed by age and gender

Figure 3. Income from employment and public transfer income in euros (€) before and after diagnosis of lung cancer for patients (case – green) and controls (blue)